ANGPT2 weakens TIE2-mediated vascular stabilization signals, making tumor vessels more responsive to VEGF and contributing to abnormal angiogenesis, immunosuppression, and tolerance to anti-angiogenic therapy.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.